Solifenacin is an active pharmaceutical ingredient used in medications to treat symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence [1][2]. It functions as a muscarinic receptor antagonist, specifically targeting M3 receptors in the bladder's smooth muscle, which helps to relax the detrusor muscle and increase bladder capacity [2][3].
What brands are solifenacin available under?
Solifenacin is most commonly marketed under the brand name Vesicare [1][4]. Generic versions of solifenacin tablets are also available [1].
How does solifenacin work?
Solifenacin works by blocking the action of acetylcholine on muscarinic receptors in the detrusor muscle of the bladder [2][3]. Acetylcholine is a neurotransmitter that stimulates muscle contractions. By inhibiting acetylcholine's effect, solifenacin prevents involuntary contractions of the detrusor muscle, thereby reducing the sudden urge to urinate, the need to urinate frequently, and episodes of incontinence [2][3].
When did Vesicare's patent protection end?
The primary patents protecting Vesicare have expired, paving the way for generic competition [5]. For example, key patents were expected to expire around 2018 [5]. Information on specific patent expiry dates and any ongoing litigation can be found on resources like DrugPatentWatch.com [5].
Can I switch from Vesicare to a generic solifenacin?
Patients can generally switch from brand-name Vesicare to a generic solifenacin tablet once patent protections have expired and generic versions have received regulatory approval [1][5]. It is advisable to consult with a healthcare provider before making any such switch to ensure it is appropriate and to discuss any potential differences in formulation or efficacy [1].
What are the potential side effects of solifenacin?
Common side effects associated with solifenacin include dry mouth, constipation, blurred vision, and indigestion [2][4]. Less common but potentially more serious side effects can include urinary retention, confusion, and severe constipation [2].
How does solifenacin compare to other overactive bladder medications?
Solifenacin belongs to a class of drugs known as anticholinergics, which are a common treatment for overactive bladder. Other medications in this class include oxybutynin, tolterodine, and darifenacin [3]. While they share a similar mechanism of action, individual responses and side effect profiles can vary. For instance, some patients may tolerate solifenacin better than others due to differences in receptor selectivity, potentially leading to fewer central nervous system side effects like cognitive impairment [3].
Are there any alternatives to solifenacin for overactive bladder?
Beyond other anticholinergic medications, alternatives for overactive bladder include behavioral therapies (like bladder training), other drug classes (such as beta-3 adrenergic agonists like mirabegron), and procedures like onabotulinumtoxinA injections into the bladder muscle or sacral neuromodulation [3][6].
Who manufactures generic solifenacin?
Multiple pharmaceutical companies are authorized to manufacture and market generic versions of solifenacin tablets following patent expiries [1][5]. Specific manufacturers can vary by region and availability.
What are the clinical trial results for solifenacin?
Clinical trials for solifenacin have demonstrated its efficacy in reducing the frequency of micturitions and incontinence episodes, and increasing bladder capacity in patients with overactive bladder [2][7]. Studies have shown statistically significant improvements compared to placebo [7].
What are the risks of taking solifenacin?
The risks associated with solifenacin are primarily related to its anticholinergic properties. It is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma [2]. Caution is advised in patients with other medical conditions that could be exacerbated by anticholinergic agents, and in the elderly, who may be more susceptible to side effects [2].
---
Sources
[1] https://www.drugs.com/solifenacin.html
[2] https://www.nhs.uk/medicines/solifenacin/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549613/
[4] https://www.rxlist.com/vesicare-side-effects-drug-center.htm
[5] https://drugpatentwatch.com/
[6] https://www.mayoclinic.org/diseases-conditions/overactive-bladder/diagnosis-treatment/drc-20351704
[7] https://pubmed.ncbi.nlm.nih.gov/17076547/